Other Assets, Noncurrent in USD of LEXICON PHARMACEUTICALS, INC. from Q4 2010 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of noncurrent assets classified as other.
Summary
LEXICON PHARMACEUTICALS, INC. quarterly Other Assets, Noncurrent history and change rate from Q4 2010 to Q3 2025.
  • LEXICON PHARMACEUTICALS, INC. Other Assets, Noncurrent for the quarter ending 30 Sep 2025 was $368K, a 55.6% decline year-over-year.
Other Assets, Noncurrent, Quarterly (USD)
Other Assets, Noncurrent, YoY Quarterly Change (%)

LEXICON PHARMACEUTICALS, INC. Quarterly Other Assets, Noncurrent (USD)

Period Value YoY Chg Change % Date Report Filed
Q3 2025 $368K -$460K -55.6% 30 Sep 2025 10-Q 06 Nov 2025
Q2 2025 $368K -$460K -55.6% 30 Jun 2025 10-Q 06 Aug 2025
Q1 2025 $368K -$460K -55.6% 31 Mar 2025 10-Q 14 May 2025
Q4 2024 $368K -$460K -55.6% 31 Dec 2024 10-Q 06 Nov 2025
Q3 2024 $828K +$85K +11.4% 30 Sep 2024 10-Q 13 Nov 2024
Q2 2024 $828K -$5.43M -86.8% 30 Jun 2024 10-Q 02 Aug 2024
Q1 2024 $828K -$5.59M -87.1% 31 Mar 2024 10-Q 02 May 2024
Q4 2023 $828K +$416K +101% 31 Dec 2023 10-K 07 Mar 2025
Q3 2023 $743K -$6.4M -89.6% 30 Sep 2023 10-Q 08 Nov 2023
Q2 2023 $6.26M +$4.41M +239% 30 Jun 2023 10-Q 04 Aug 2023
Q1 2023 $6.42M +$4.36M +211% 31 Mar 2023 10-Q 04 May 2023
Q4 2022 $412K -$1.86M -81.8% 31 Dec 2022 10-K 25 Mar 2024
Q3 2022 $7.15M +$4.68M +189% 30 Sep 2022 10-Q 09 Nov 2022
Q2 2022 $1.85M -$821K -30.7% 30 Jun 2022 10-Q 03 Aug 2022
Q1 2022 $2.06M -$943K -31.4% 31 Mar 2022 10-Q 05 May 2022
Q4 2021 $2.27M +$1.04M +84.3% 31 Dec 2021 10-Q 09 Nov 2022
Q3 2021 $2.47M +$1.13M +84.3% 30 Sep 2021 10-Q 09 Nov 2021
Q2 2021 $2.67M +$1.22M +84.4% 30 Jun 2021 10-Q 06 Aug 2021
Q1 2021 $3.01M +$1.45M +93.5% 31 Mar 2021 10-Q 06 May 2021
Q4 2020 $1.23M -$424K -25.6% 31 Dec 2020 10-K 10 Mar 2022
Q3 2020 $1.34M -$413K -23.5% 30 Sep 2020 10-Q 30 Oct 2020
Q2 2020 $1.45M -$450K -23.7% 30 Jun 2020 10-Q 29 Jul 2020
Q1 2020 $1.55M -$440K -22.1% 31 Mar 2020 10-Q 27 Apr 2020
Q4 2019 $1.66M +$1.37M +481% 31 Dec 2019 10-K 12 Mar 2021
Q3 2019 $1.75M +$1.33M +309% 30 Sep 2019 10-Q 07 Nov 2019
Q2 2019 $1.9M +$1.47M +342% 30 Jun 2019 10-Q 01 Aug 2019
Q1 2019 $1.99M +$1.56M +361% 31 Mar 2019 10-Q 01 May 2019
Q4 2018 $285K -$144K -33.6% 31 Dec 2018 10-K 12 Mar 2020
Q3 2018 $429K $0 0% 30 Sep 2018 10-Q 01 Nov 2018
Q2 2018 $429K +$1K +0.23% 30 Jun 2018 10-Q 30 Jul 2018
Q1 2018 $432K +$4K +0.94% 31 Mar 2018 10-Q 03 May 2018
Q4 2017 $429K -$32K -6.94% 31 Dec 2017 10-K 15 Mar 2019
Q3 2017 $429K -$25K -5.51% 30 Sep 2017 10-Q 08 Nov 2017
Q2 2017 $428K -$2K -0.47% 30 Jun 2017 10-Q 01 Aug 2017
Q1 2017 $428K -$102K -19.2% 31 Mar 2017 10-Q 04 May 2017
Q4 2016 $461K +$28K +6.47% 31 Dec 2016 10-K 01 Mar 2018
Q3 2016 $454K -$3.04M -87% 30 Sep 2016 10-Q 07 Nov 2016
Q2 2016 $430K -$3.15M -88% 30 Jun 2016 10-Q 04 Aug 2016
Q1 2016 $530K -$3.21M -85.8% 31 Mar 2016 10-Q 05 May 2016
Q4 2015 $433K -$2.98M -87.3% 31 Dec 2015 10-K 06 Mar 2017
Q3 2015 $3.5M +$3.39M +3139% 30 Sep 2015 10-Q 09 Nov 2015
Q2 2015 $3.58M +$3.46M +2884% 30 Jun 2015 10-Q 07 Aug 2015
Q1 2015 $3.74M +$3.61M +2712% 31 Mar 2015 10-Q 05 May 2015
Q4 2014 $3.41M +$3.27M +2267% 31 Dec 2014 10-K 11 Mar 2016
Q3 2014 $108K -$50K -31.6% 30 Sep 2014 10-Q 06 Nov 2014
Q2 2014 $120K +$55K +84.6% 30 Jun 2014 10-Q 07 Aug 2014
Q1 2014 $133K +$45K +51.1% 31 Mar 2014 10-Q 08 May 2014
Q4 2013 $144K +$35K +32.1% 31 Dec 2013 10-K 12 Mar 2015
Q3 2013 $158K +$23K +17% 30 Sep 2013 10-Q 12 Nov 2013
Q2 2013 $65K -$92K -58.6% 30 Jun 2013 10-Q 01 Aug 2013
Q1 2013 $88K -$93K -51.4% 31 Mar 2013 10-Q 10 May 2013
Q4 2012 $109K -$96K -46.8% 31 Dec 2012 10-K 07 Mar 2014
Q3 2012 $135K -$146K -52% 30 Sep 2012 10-Q 07 Nov 2012
Q2 2012 $157K -$96K -37.9% 30 Jun 2012 10-Q 02 Aug 2012
Q1 2012 $181K 31 Mar 2012 10-Q 03 May 2012
Q4 2011 $205K -$414K -66.9% 31 Dec 2011 10-K 11 Mar 2013
Q3 2011 $281K 30 Sep 2011 10-Q 01 Nov 2011
Q2 2011 $253K 30 Jun 2011 10-Q 09 Aug 2011
Q4 2010 $619K 31 Dec 2010 10-K 08 Mar 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.